Phosphatase-mediated crosstalk between MAPK signalling pathways in the regulation of cell survival

被引:668
作者
Junttila, Melissa R. [1 ,2 ]
Li, Song-Ping [3 ,4 ]
Westermarck, Jukka [1 ,2 ,5 ]
机构
[1] Univ Turku, Turku Ctr Biotechnol, Turku, Finland
[2] Abo Akad Univ, Turku, Finland
[3] Univ Helsinki, Inst Biomed, Helsinki, Finland
[4] Natl Publ Hlth Inst KTL, Helsinki, Finland
[5] Univ Tampere, Inst Med Technol, Tampere 33250, Finland
关键词
protein phosphatase; MKK; p38; ERK; transformation; cancer;
D O I
10.1096/fj.06-7859rev
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mitogen-activated protein kinase (MAPK) pathways constitute a large modular network that regulates a variety of physiological processes, such as cell growth, differentiation, and apoptotic cell death. The function of the ERK pathway has been depicted as survival-promoting, in essence by opposing the proapoptotic activity of the stress-activated c-Jun NH2 terminal kinase (JNK)/p38 MAPK pathways. However, recently published work suggests that extracellular regulated kinase (ERK) pathway activity is suppressed by JNK/p38 kinases during apoptosis induction. In this review, we will summarize the current knowledge about JNK/p38-mediated mechanisms that negatively regulate the ERK pathway. In particular, we will focus on phosphatases (PP2A, MKPs) as inhibitors of ERK pathway activity in regulating apoptosis. A model proposed in this review places the negative regulation of the ERK pathway in a central position for the cellular decision-making process that determines whether cells will five or die in response to apoptosis-promoting signals. In addition, we will discuss the potential functional relevance of negative regulation of ERK pathway activity, for physiological and pathological conditions (e.g:, cellular transformation).
引用
收藏
页码:954 / 965
页数:12
相关论文
共 132 条
  • [1] Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation
    Abraham, D
    Podar, K
    Pacher, M
    Kubicek, M
    Welzel, N
    Hemmings, BA
    Dilworth, SM
    Mischak, H
    Kolch, W
    Baccarini, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (29) : 22300 - 22304
  • [2] SELECTIVE REQUIREMENT FOR MAP KINASE ACTIVATION IN THYMOCYTE DIFFERENTIATION
    ALBEROLAILA, J
    FORBUSH, KA
    SEGER, R
    KREBS, EG
    PERLMUTTER, RM
    [J]. NATURE, 1995, 373 (6515) : 620 - 623
  • [3] Protein tyrosine phosphatases in the human genome
    Alonso, A
    Sasin, J
    Bottini, N
    Friedberg, I
    Friedberg, I
    Osterman, A
    Godzik, A
    Hunter, T
    Dixon, J
    Mustelin, T
    [J]. CELL, 2004, 117 (06) : 699 - 711
  • [4] TEF-1 and C/EBPβ are major p38α MAR-regulated transcription factors in proliferating cardiomyocytes
    Ambrosino, Concetta
    Iwata, Tomoko
    Scafoglio, Claudio
    Mallardo, Massimo
    Klein, Ruediger
    Nebreda, Angel R.
    [J]. BIOCHEMICAL JOURNAL, 2006, 396 : 163 - 172
  • [5] Involvement of PP2A in viral and cellular transformation
    Arroyo, JD
    Hahn, WC
    [J]. ONCOGENE, 2005, 24 (52) : 7746 - 7755
  • [6] The many paths to p38 mitogen-activated protein kinase activation in the immune system
    Ashwell, Jonathan D.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2006, 6 (07) : 532 - 540
  • [7] Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397
  • [8] Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions
    Biondi, RM
    Nebreda, AR
    [J]. BIOCHEMICAL JOURNAL, 2003, 372 : 1 - 13
  • [9] Cell transformation by v-Jun deactivates ERK MAP kinase signalling
    Black, EJ
    Walker, M
    Clark, W
    MacLaren, A
    Gillespie, DAF
    [J]. ONCOGENE, 2002, 21 (42) : 6540 - 6548
  • [10] Molecular cloning of mitogen-activated protein ERK kinase kinases (MEKK) 2 and 3 - Regulation of sequential phosphorylation pathways involving mitogen-activated protein kinase and c-Jun kinase
    Blank, JL
    Gerwins, P
    Elliott, EM
    Sather, S
    Johnson, GL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (10) : 5361 - 5368